Logo image of QTRX

QUANTERIX CORP (QTRX) Stock Fundamental Analysis

NASDAQ:QTRX - Nasdaq - US74766Q1013 - Common Stock - Currency: USD

5.89  +0.03 (+0.6%)

After market: 5.999 +0.11 (+1.85%)

Fundamental Rating

4

Taking everything into account, QTRX scores 4 out of 10 in our fundamental rating. QTRX was compared to 55 industry peers in the Life Sciences Tools & Services industry. While QTRX has a great health rating, there are worries on its profitability. QTRX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

QTRX had negative earnings in the past year.
QTRX had a negative operating cash flow in the past year.
In the past 5 years QTRX always reported negative net income.
In the past 5 years QTRX always reported negative operating cash flow.
QTRX Yearly Net Income VS EBIT VS OCF VS FCFQTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.89%, QTRX is in line with its industry, outperforming 50.91% of the companies in the same industry.
QTRX has a Return On Equity (-18.66%) which is in line with its industry peers.
Industry RankSector Rank
ROA -14.89%
ROE -18.66%
ROIC N/A
ROA(3y)-12.78%
ROA(5y)-12.3%
ROE(3y)-15.57%
ROE(5y)-15.02%
ROIC(3y)N/A
ROIC(5y)N/A
QTRX Yearly ROA, ROE, ROICQTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

QTRX's Gross Margin of 59.32% is fine compared to the rest of the industry. QTRX outperforms 76.36% of its industry peers.
QTRX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for QTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5Y5.05%
QTRX Yearly Profit, Operating, Gross MarginsQTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

QTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
QTRX has more shares outstanding than it did 1 year ago.
QTRX has more shares outstanding than it did 5 years ago.
QTRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QTRX Yearly Shares OutstandingQTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
QTRX Yearly Total Debt VS Total AssetsQTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

QTRX has an Altman-Z score of 0.63. This is a bad value and indicates that QTRX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.63, QTRX is doing worse than 67.27% of the companies in the same industry.
QTRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC10.6%
QTRX Yearly LT Debt VS Equity VS FCFQTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

QTRX has a Current Ratio of 8.29. This indicates that QTRX is financially healthy and has no problem in meeting its short term obligations.
QTRX has a better Current ratio (8.29) than 90.91% of its industry peers.
QTRX has a Quick Ratio of 7.53. This indicates that QTRX is financially healthy and has no problem in meeting its short term obligations.
QTRX's Quick ratio of 7.53 is amongst the best of the industry. QTRX outperforms 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 8.29
Quick Ratio 7.53
QTRX Yearly Current Assets VS Current LiabilitesQTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for QTRX have decreased strongly by -23.96% in the last year.
QTRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.16%.
Measured over the past years, QTRX shows a quite strong growth in Revenue. The Revenue has been growing by 19.37% on average per year.
EPS 1Y (TTM)-23.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.54%
Revenue 1Y (TTM)33.16%
Revenue growth 3Y7.51%
Revenue growth 5Y19.37%
Sales Q2Q%-5.4%

3.2 Future

QTRX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.97% yearly.
Based on estimates for the next years, QTRX will show a quite strong growth in Revenue. The Revenue will grow by 16.03% on average per year.
EPS Next Y-57.46%
EPS Next 2Y7.31%
EPS Next 3Y13.45%
EPS Next 5Y0.97%
Revenue Next Year-8.84%
Revenue Next 2Y2.16%
Revenue Next 3Y6.72%
Revenue Next 5Y16.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
QTRX Yearly Revenue VS EstimatesQTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
QTRX Yearly EPS VS EstimatesQTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QTRX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QTRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTRX Price Earnings VS Forward Price EarningsQTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTRX Per share dataQTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as QTRX's earnings are expected to grow with 13.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.31%
EPS Next 3Y13.45%

More info and screens

0

5. Dividend

5.1 Amount

QTRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTERIX CORP

NASDAQ:QTRX (7/11/2025, 8:00:02 PM)

After market: 5.999 +0.11 (+1.85%)

5.89

+0.03 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners89.8%
Inst Owner Change0%
Ins Owners5.62%
Ins Owner Change8.08%
Market Cap228.71M
Analysts78.18
Price Target11.63 (97.45%)
Short Float %8.91%
Short Ratio4.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.82%
Min EPS beat(2)-15.34%
Max EPS beat(2)5.7%
EPS beat(4)3
Avg EPS beat(4)2.6%
Min EPS beat(4)-15.34%
Max EPS beat(4)11.96%
EPS beat(8)6
Avg EPS beat(8)16.32%
EPS beat(12)7
Avg EPS beat(12)2.29%
EPS beat(16)10
Avg EPS beat(16)3.18%
Revenue beat(2)2
Avg Revenue beat(2)2.77%
Min Revenue beat(2)0.1%
Max Revenue beat(2)5.44%
Revenue beat(4)4
Avg Revenue beat(4)2.08%
Min Revenue beat(4)0.02%
Max Revenue beat(4)5.44%
Revenue beat(8)7
Avg Revenue beat(8)5.02%
Revenue beat(12)9
Avg Revenue beat(12)2.8%
Revenue beat(16)13
Avg Revenue beat(16)3.5%
PT rev (1m)-5.65%
PT rev (3m)-16.59%
EPS NQ rev (1m)-3.88%
EPS NQ rev (3m)-44.09%
EPS NY rev (1m)-22%
EPS NY rev (3m)-23.64%
Revenue NQ rev (1m)-2.76%
Revenue NQ rev (3m)-19.12%
Revenue NY rev (1m)-2.87%
Revenue NY rev (3m)-12.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.36
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)-1.19
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS4.32
BVpS8.15
TBVpS7.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.89%
ROE -18.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.32%
FCFM N/A
ROA(3y)-12.78%
ROA(5y)-12.3%
ROE(3y)-15.57%
ROE(5y)-15.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5Y5.05%
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.77%
Cap/Sales 2.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.29
Quick Ratio 7.53
Altman-Z 0.63
F-Score4
WACC10.6%
ROIC/WACCN/A
Cap/Depr(3y)110.86%
Cap/Depr(5y)140.92%
Cap/Sales(3y)5.57%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.54%
EPS Next Y-57.46%
EPS Next 2Y7.31%
EPS Next 3Y13.45%
EPS Next 5Y0.97%
Revenue 1Y (TTM)33.16%
Revenue growth 3Y7.51%
Revenue growth 5Y19.37%
Sales Q2Q%-5.4%
Revenue Next Year-8.84%
Revenue Next 2Y2.16%
Revenue Next 3Y6.72%
Revenue Next 5Y16.03%
EBIT growth 1Y-46.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-15.14%
EBIT Next 3Y15.87%
EBIT Next 5YN/A
FCF growth 1Y29.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.91%
OCF growth 3YN/A
OCF growth 5YN/A